Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 6, 2001, Pages 739-743

  McShane, R H ^a,d   Nagy, Z ^b   Esiri, M M ^c   King, E ^a   Joachim, C ^c   Sullivan, N ^c   Smith, A D ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Department of Neuropathology ^*

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Consensus criteria; Dementia with Lewy bodies; Olfaction

Indexed keywords

AGED; ALZHEIMER DISEASE; ANOSMIA; ARTICLE; DEMENTIA; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; DEMENTIA; FEMALE; HUMANS; LEWY BODIES; MALE; OLFACTION DISORDERS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0034988853     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.6.739     Document Type: Article

References (35)

1. Doty RL, Riklan M, Deems DA, et al. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol 1989;25:166-71.
2. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:436-46.
3. Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 1991;148:357-60.
4. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987;18:597-600.
5. Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol B Psychol Sci Soc Sci 1995;50:187-92.
6. Koss E, Weiffenbach JM, Haxby JV, et al. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988;38:1228-32.
7. Rezek DL. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Arch Neurol 1987;44:1030-2.
8. Larsson M, Semb H, Winblad B, et al. Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support. Neuropsychology 1999;13:47-53.
9. Mesholam RI, Moberg PJ, Mahr RN, et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998;55:84-90.
10. Nordin S, Almkvist O, Berglund B, et al. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Arch Neurol 1997;54:993-8.
11. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
12. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1988;24:50-6.
13. Gibb WR, Mann DM, Mountjoy CQ, et al. A pathological study of the association between Lewy body disease and Alzheimer's disease. Acta Neurol 1990;53:55-9.
14. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile changes in the cerebral grey matter of elderly subjects. Br J Psychol 1968;225:797-811.
15. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
16. Doty RL, Shaman P, Kimmelman CP, et al. University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984;94: 176-8.
17. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
18. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
19. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-86.
20. Nagy Z, Yilmazer HD, Braak H, et al. Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord 1998;9:140-4.
21. Kovács T, Cairns NJ, Lantos PL. β-Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 1999;25:481-91.
22. Schmidt ML, Martin JA, Lee VM, et al. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol Berl 1996;91:475-81.
23. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-7.
24. Esiri MM, Wilcock GK. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1984;47:56-60.
25. Murphy C, Gilmore MM, Seery CS, et al. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging 1990;11:465-9.
26. Kuljis RO, Martin-Vasallo P, Peress NS. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett 1989;106:49-54.
27. Yousem DM, Maldjian JA, Hummel T, et al. The effect of age on odor-stimulated functional MR imaging. AJNR Am J Neuroradiol 1999;20:600-8.
28. Levy LM, Henkin RI, Hutter A, et al. Mapping brain activation to odorants in patients with smell loss by functional MRI. J Comput Assist Tomogr 1998;22:96-103.
29. Takeda A, Hashimoto M, Mallory M, et al. C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol 2000;99:296-304.
30. Mukaetova-Ladinska EB, Hurt J, Jakes R, et al. α-Synuclein inclusions in Alzheimer and Lewy body diseases. J Neuropathol Exp Neurol 2000;59:408-17.
31. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies [letter]. Nature 1997;388:839-40.
32. Doty RL, McKeown DA, Lee WW, et al. A study of the test-retest reliability of 10 olfactory tests. Chem Senses 1995;20: 645-56.
33. Nordin S, Murphy C. Odor memory in normal aging and Alzheimer's disease. Ann N Y Acad Sci 1998;855:686-93.
34. Murphy C, Bacon AW, Bondi MW, et al. Apolipoprotein E status is associated with odor identification deficits in non-demented older persons. Ann N Y Acad Sci 1998;855:744-50.
35. Graves AB, Bowen JD, Rajaram L, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999;53: 1480-7.